Puffy under-eye bags are often related to lifestyle choices, such as smoking or not sleeping enough. Find ways to minimize ...
4d
The Brighterside of News on MSNSay goodbye to reading glasses: New eye drops are revolutionizing vision careA new prescription eye drop called Vuity is offering a fresh solution for people struggling with presbyopia, a common ...
Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...
Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...
AbbVie's combination antibiotic Emblaveo has gotten federal approval to treat complicated intra-abdominal infections, making it the first and only such therapy approved to fight antimicrobial ...
The study demonstrated that LL-BMT1 provided similar therapeutic results as a once-a-week solution to the comparator, 0.01% bimatoprost eye drop, offering a significant dosing advantage over one or ...
Okay, we exaggerate but have you seen the size of some supplement tablets? Or you often end up with a wet face when applying eye drops because you can't help but blink. It’s a tale as old as the need ...
In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other stocks. Jim Cramer, the host of Mad Money, on Tuesday, took a close look at President Donald ...
AbbVie’s Skyrizi was responsible for the highest TV advertising outlay in pharma in most months of 2024, but 2025 is starting off on a very different note. According to iSpot.TV’s analysis of ...
Jessica was a writer on the Wellness team, with a focus on health technology, eye care, nutrition and finding new approaches to chronic health problems. We're glued to different types of screens ...
Q4 2024 Results: Strong Revenue Beat, Driven by Skyrizi, Rinvoq, Neuroscience and Eye Care Outperformance AbbVie delivered $15.1 billion in Q4 revenues, beating the analyst consensus by $270 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results